Grantham, Mayo, Van Otterloo & Co (GMO)’s Morgan Stanley MS Stock Holding History
Bought
Maintained
Sold
Other funds holding MS
VCM
VPM
Grantham, Mayo, Van Otterloo & Co (GMO)'s MS Position: Q1 2026 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Morgan Stanley (MS) stake by 33% in Q1 2026, selling an estimated $1.68M and leaving 19,390 shares worth $3.19M. The position accounts for 0.01% of the portfolio, ranked #384.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MS in Q2 2013 and has held it in 23 quarters since. The position peaked at $34M in Q3 2013. 2,488 funds tracked by Wall St. Rank hold MS as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) held 19,390 shares of Morgan Stanley worth $3.19M as of Q1 2026.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 9,680 Morgan Stanley shares in Q1 2026, an estimated $1.68M.
- Morgan Stanley made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #384 holding.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Morgan Stanley in Q2 2013 and has held it in 23 quarters since.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Morgan Stanley position peaked at $34M in Q3 2013.
- 2,488 funds tracked by Wall St. Rank held Morgan Stanley as of Q1 2026.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.